In 1975, Georges Köhler and César Milstein, biochemists from the Medical Research Council Laboratory of Molecular Biology, published a paper in Nature about a hybridoma technology that enabled the ...

Monoclonal antibodies (mAbs) are nature's biological warheads, able to target and help eliminate foreign or abnormal agents from the body. In theory, replicating this powerful defense system could ...

(Image: National Cancer Institute) The production of monoclonal antibodies involves a multi-step process called hybridoma technology, which was first developed by Georges Köhler and César Milstein in ...

This was the discovery that allowed the exploitation of antibodies in science and medicine and is now the basis of a multi billion pound industry. Milstein himself went on to develop monoclonal ...